Publications

Integrative clinical and preclinical studies identify FerroTerminator1 as a potent therapeutic drug for MASH

 54
Integrative clinical and preclinical studies identify FerroTerminator1 as a potent therapeutic drug for MASH

Tags:

Previous Article

Human Schwann cell lipid dysregulation and plasma membrane perturbation in Charc...

Next Article

FerroTerminator1 as a potent therapeutic drug for MASH

Related Posts

Bioelectronic drug-free control of opportunistic pathogens through selective excitability

Bioelectronic drug-free control of opportunistic pathog...

 79

The 2024 Nobel Prize in Physiology or Medicine

The 2024 Nobel Prize in Physiology or Medicine

 43

Advances in cell therapy: progress and challenges in hematological and solid tumors

Advances in cell therapy: progress and challenges in he...

 70